Playback speed
10 seconds
Is Chemo the Key for EGFR Mutation-Positive NSCLC? The Data Too Good to Overlook
By
Beacon Medical Interchange
FEATURING
Jack West
By
Beacon Medical Interchange
FEATURING
Jack West
0 views
November 2, 2018
Dr. Jack West reviews the remarkable results of the NEJ009 trial that tested the combination ...
read more ↘ of carboplatin/pemetrexed with gefitinib as initial therapy compared to gefitinib followed by chemotherapy in patients with EGFR mutation-positive advanced NSCLC.
↖ read less
read more ↘ of carboplatin/pemetrexed with gefitinib as initial therapy compared to gefitinib followed by chemotherapy in patients with EGFR mutation-positive advanced NSCLC.
↖ read less
Comments 2
Login to view comments.
Click here to Login
Lung